tradingkey.logo
tradingkey.logo
Suchen

Champions Oncology Inc

CSBR
Zur Watchlist hinzufügen
5.760USD
-0.120-1.97%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
79.99MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Champions Oncology Inc Unternehmen

Champions Oncology, Inc. is a preclinical and clinical research services provider. The Company is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions. This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. It also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.

Champions Oncology Inc Informationen

BörsenkürzelCSBR
Name des UnternehmensChampions Oncology Inc
IPO-datumNov 30, 1988
CEOBrainin (Robert)
Anzahl der mitarbeiter213
WertpapierartOrdinary Share
GeschäftsjahresendeNov 30
AddresseOne University Plaza,
StadtHACKENSACK
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl07601
Telefon12018088400
Websitehttps://championsoncology.com
BörsenkürzelCSBR
IPO-datumNov 30, 1988
CEOBrainin (Robert)

Führungskräfte von Champions Oncology Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Joel Ackerman
Mr. Joel Ackerman
Independent Director
Independent Director
1.06M
+8.94%
Dr. Ronnie Morris, M.D.
Dr. Ronnie Morris, M.D.
Chairman of the Board
Chairman of the Board
858.88K
--
Dr. David Sidransky, M.D.
Dr. David Sidransky, M.D.
Independent Director
Independent Director
767.04K
--
Mr. Scott R. Tobin
Mr. Scott R. Tobin
Independent Director
Independent Director
53.40K
+43.82%
Mr. Daniel N. (Dan) Mendelson
Mr. Daniel N. (Dan) Mendelson
Independent Director
Independent Director
--
--
Mr. David Miller, CPA
Mr. David Miller, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Philip Breitfeld, M.D.
Dr. Philip Breitfeld, M.D.
Independent Director
Independent Director
--
--
Mr. Robert (Rob) Brainin
Mr. Robert (Rob) Brainin
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Joel Ackerman
Mr. Joel Ackerman
Independent Director
Independent Director
1.06M
+8.94%
Dr. Ronnie Morris, M.D.
Dr. Ronnie Morris, M.D.
Chairman of the Board
Chairman of the Board
858.88K
--
Dr. David Sidransky, M.D.
Dr. David Sidransky, M.D.
Independent Director
Independent Director
767.04K
--
Mr. Scott R. Tobin
Mr. Scott R. Tobin
Independent Director
Independent Director
53.40K
+43.82%
Mr. Daniel N. (Dan) Mendelson
Mr. Daniel N. (Dan) Mendelson
Independent Director
Independent Director
--
--
Mr. David Miller, CPA
Mr. David Miller, CPA
Chief Financial Officer
Chief Financial Officer
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Champions Oncology Inc?

Die fünf größten Anteilseigner von Champions Oncology Inc sind: Mr. Joel Ackerman

Wie viele Institutionen halten Anteile an Champions Oncology Inc (CSBR)?

Mit Stand vom 2026Q1 halten 61 Institutionen Anteile an Champions Oncology Inc, mit einem Gesamtmarktwert von etwa 6.66M, was 47.97% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -413745.00 gestiegen.